Search

Your search keyword '"Geneviève Durrieu"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Geneviève Durrieu" Remove constraint Author: "Geneviève Durrieu"
125 results on '"Geneviève Durrieu"'

Search Results

1. Interactions between medical residents and drug companies: a national survey after the Mediator® affair.

2. Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase®

4. Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysis

8. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database

9. Drug-Induced Hearing Loss in Children: An Analysis of Spontaneous Reports in the French PharmacoVigilance Database

10. Can tramadol really induce hyponatraemia? A pharmacovigilance study

11. Informativité des déclarations de pharmacovigilance en médecine générale en France

12. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports

13. Does spontaneous adverse drug reactions’ reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre

14. Are lipid‐lowering drugs associated with a risk of cataract? A pharmacovigilance study

15. Fasciites à éosinophiles induites par les médicaments: double analyse de pharmacovigilance

16. Satisfaction des médecins généralistes d’un réseau d’aide à la déclaration de pharmacovigilance PharmacoMIP-MG

17. Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults

18. Adverse Drug Reactions, Iatrogenic Diseases, Drug Safety, and Pharmacovigilance: Importance and Interest for Patients and Their Physicians

19. Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in France

20. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019

21. Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations

22. Neurological Adverse Effects Associated With Anti-tumor Necrosis Factor Alpha Antibodies in Pediatric Inflammatory Bowel Diseases

23. [Completeness of pharmacovigilance reporting in general medicine in France.]

24. Tamoxifen and the risk of Parkinsonism: a case/non-case study

25. Pharmacovigilance in pediatrics

26. Reconciling a 'pleasant exchange' with evidence of information bias: A three-country study on pharmaceutical sales visits in primary care

27. Tintin in the Land of Drugs: A pharmacological, pharmacovigilance approach

28. Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting

29. Drugs and Dupuytren’s disease: a pharmacovigilance study in VigiBase®

30. Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns

31. Atropinic (anticholinergic) burden in antipsychotic-treated patients

32. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database

33. Can drugs induce or aggravate sleep apneas? A case-noncase study in VigiBase®, the WHO pharmacovigilance database

34. Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®

35. Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey

36. Liquid formulation of ifosfamide increased risk of encephalopathy: A case-control study in a pediatric population

37. Methylprednisolone-related liver injury: A descriptive study using the French pharmacovigilance database

38. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study

39. Pharmacovigilance, risks and adverse effects of self-medication

40. Pharmacovigilance : risques et effets indésirables de l’automédication

41. Atropinic (Anticholinergic) Burden in Parkinson's Disease

42. Lipid-lowering drugs and the risk of cataract: An Observational Post Marketing Study

43. Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics

44. Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase

45. Eur J Clin Pharmacol

46. [Satisfaction of a pharmacovigilance declaration support network in general practice]

47. Off-label and unlicensed drug use in children population

48. Medication errors with tramadol drops in children

49. Statins and diabetes: is there any difference between the different statins?

50. Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital

Catalog

Books, media, physical & digital resources